These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38881923)

  • 1.
    Wang X; Zhu HQ; Lin SM; Xia BY; Xu B
    Transl Cancer Res; 2024 May; 13(5):2518-2534. PubMed ID: 38881923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer analysis of the disulfidptosis-related gene
    Zong Y; Zhu A; Liu P; Fu P; Li Y; Chen S; Gao X
    Heliyon; 2024 Jun; 10(11):e31875. PubMed ID: 38845861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifies microtubule-binding protein
    Wang W; Zhang J; Wang Y; Xu Y; Zhang S
    Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
    Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
    Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-Omics Insights into Disulfidptosis-Related Genes Reveal RPN1 as a Therapeutic Target for Liver Cancer.
    He Y; Hu Y; Cheng Y; Li X; Chen C; Zhang S; He H; Cao F
    Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of disulfidptosis-related immune genes signature to boost the efficacy of prognostic prediction in gastric cancer.
    Li J; Yu T; Sun J; Ma M; Zheng Z; He Y; Kang W; Ye X
    Cancer Cell Int; 2024 Mar; 24(1):112. PubMed ID: 38528532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfidptosis-related Protein RPN1 may be a Novel Anti-osteoporosis Target of Kaempferol.
    Pan C; Zhang C; Lin Z; Liang Z; Cui Y; Shang Z; Wei Y; Chen F
    Comb Chem High Throughput Screen; 2024; 27(11):1611-1628. PubMed ID: 38213143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer.
    Li L; Feng Q; Wang X
    Comput Struct Biotechnol J; 2020; 18():668-675. PubMed ID: 32257050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Oncogenic Role of Disulfidptosis-related Gene SLC7A11 in Anti-tumor Immunotherapy Response to Human Cancers.
    Xu B; Liang J; Fu L; Wei J; Lin J
    Curr Cancer Drug Targets; 2024; 24(8):846-866. PubMed ID: 38303526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts.
    Zeng Z; Gao Y; Li J; Zhang G; Sun S; Wu Q; Gong Y; Xie C
    Comput Struct Biotechnol J; 2022; 20():496-507. PubMed ID: 35070171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion.
    Li P; Wang S; Wan H; Huang Y; Yin K; Sun K; Jin H; Wang Z
    Front Immunol; 2024; 15():1258475. PubMed ID: 38352883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The disulfidptosis-related signature predicts prognosis and immune features in glioma patients.
    Wang X; Yang J; Yang F; Mu K
    Sci Rep; 2023 Oct; 13(1):17988. PubMed ID: 37864127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA.
    Ye B; Shi J; Kang H; Oyebamiji O; Hill D; Yu H; Ness S; Ye F; Ping J; He J; Edwards J; Zhao YY; Guo Y
    RNA Biol; 2020 Nov; 17(11):1666-1673. PubMed ID: 31607216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the prognostic value of constructing disulfidptosis-related gene models for lung adenocarcinoma patients.
    Luo M; Liu RZ; Li YJ; Zhang SD; Wu ZY
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9569-9585. PubMed ID: 37916324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.
    Huang Y; Chen D; Bai Y; Zhang Y; Zheng Z; Fu Q; Yi B; Jiang Y; Zhang Z; Zhu J
    BMC Cancer; 2024 Apr; 24(1):452. PubMed ID: 38605349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
    Guo B; Wang Y; Liu W; Zhang S
    Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of Disulfidptosis-related Genes and Functional Analysis in Gastric Cancer.
    Yan J; Fang Z; Shi M; Tu C; Zhang S; Jiang C; Li Q; Shao Y
    J Cancer; 2024; 15(4):1053-1066. PubMed ID: 38230212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.